Clostridium Butyricum ZJU-F1 Benefits the Intestinal Barrier Function and Immune Response Associated with Its Modulation of Gut Microbiota in Weaned Piglets
- 2021-03-02
- Cells 10(3)
- Jie Fu
- Tenghao Wang
- Xinxin Xiao
- Yuanzhi Cheng
- Fengqin Wang
- M. Jin
- Yizhen Wang
- X. Zong
- PubMed: 33801396
- DOI: 10.3390/cells10030527
Abstract
This study investigated the effects of dietary C. butyricum ZJU-F1 on the apparent digestibility of nutrients, intestinal barrier function, immune response, and microflora of weaned piglets, with the aim of providing a theoretical basis for the application of Clostridium butyricum as an alternative to antibiotics in weaned piglets. A total of 120 weanling piglets were randomly divided into four treatment groups, in which piglets were fed a basal diet supplemented with antibiotics (CON), Bacillus licheniformis (BL), Clostridium butyricum ZJU-F1 (CB), or Clostridium butyricum and Bacillus licheniformis (CB-BL), respectively. The results showed that CB and CB-BL treatment increased the intestinal digestibility of nutrients, decreased intestinal permeability, and increased intestinal tight junction protein and mucin expression, thus maintaining the integrity of the intestinal epithelial barrier. CB and CB-BL, as exogenous probiotics, were also found to stimulate the immune response of weaned piglets and improve the expression of antimicrobial peptides in the ileum. In addition, dietary CB and CB-BL increased the proportion of Lactobacillus. The levels of butyric acid, propionic acid, acetic acid, and total acid were significantly increased in the ceca of piglets fed CB and CB-BL. Furthermore, we validated the effects of C. butyricum ZJU-F1 on the intestinal barrier function and immune response in vitro and found C. butyricum ZJU-F1 improved intestinal function and enhanced the TLR-2-MyD88-NF-κB signaling.
Keywords: C. butyricum ZJU-F1; TLR2; intestinal barrier; microbiota; weaning piglets.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Clostridium butyricum | Enhanced Immune Response | Beneficial | Large |
Clostridium butyricum | Enhanced Immunological Signaling via TLR-2-MyD88-NF-κB Pathway | Beneficial | Moderate |
Clostridium butyricum | Improved Antimicrobial Peptide Expression | Beneficial | Moderate |
Clostridium butyricum | Improved Digestibility | Beneficial | Moderate |
Clostridium butyricum | Improved Intestinal Epithelial Barrier Function | Beneficial | Moderate |
Clostridium butyricum | Improved Lactobacillus Abundance | Beneficial | Moderate |
Clostridium butyricum | Increased Short-Chain Fatty Acid Levels | Beneficial | Moderate |
Clostridium butyricum | Reduced Intestinal Permeability | Beneficial | Moderate |